CEMI Stock: Investors Cheer Commercial Launch

Chembio Diagnostics CEMI Stock News

Chembio Diagnostics Inc (NASDAQ: CEMI) is flying in the market this morning after the company issued news on Friday surrounding the commercial launch of a point-of-care COVID-19/Flu A&B test.  Here’s what’s happening: Chembio Diagnostics Announces Commercial Launch In the press release, Chembio Diagnostics said that it will be launching its in-licensed rapid point-of-care COVID-19/Flu A&B … Read more